Growth Metrics

AtriCure (ATRC) Return on Equity (2016 - 2025)

AtriCure (ATRC) has disclosed Return on Equity for 15 consecutive years, with 0.02% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 7.0% to 0.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02% through Dec 2025, up 7.0% year-over-year, with the annual reading at 0.02% for FY2025, 7.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.02% at AtriCure, up from 0.06% in the prior quarter.
  • The five-year high for Return on Equity was 0.12% in Q2 2022, with the low at 0.15% in Q2 2021.
  • Average Return on Equity over 5 years is 0.05%, with a median of 0.08% recorded in 2024.
  • Peak annual rise in Return on Equity hit 26bps in 2022, while the deepest fall reached -23bps in 2022.
  • Over 5 years, Return on Equity stood at 0.1% in 2021, then tumbled by -199bps to 0.1% in 2022, then surged by 36bps to 0.07% in 2023, then plummeted by -47bps to 0.1% in 2024, then soared by 76bps to 0.02% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.02%, 0.06%, and 0.08% for Q4 2025, Q3 2025, and Q2 2025 respectively.